Brief: GlycoMimetics Stockholders Approve Proposed Merger With Crescent Biopharma And All Related Proposals
05/06/2025 21:24
June 5 (Reuters) - GlycoMimetics Inc GLYC.O: GLYCOMIMETICS STOCKHOLDERS APPROVE PROPOSED MERGER WITH CRESCENT BIOPHARMA AND ALL RELATED PROPOSALS GLYCOMIMETICS INC - BOARD APPROVES 1-FOR-100 REVERSE STOCK SPLIT GLYCOMIMETICS INC - REVERSE STOCK SPLIT TO REDUCE OUTSTANDING SHARES TO 0.6 MILLION Source text: ID:nBw4BPZKva Further company coverage: GLYC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering